Andrographolide Suppresses Proliferation of Nasopharyngeal Carcinoma Cells via Attenuating NF-κB Pathway

Andrographolide (Andro) has been reported to have anticancer activity in multiple types of cancer due to its capacity to inactivate NF-κB pathway. Previous studies showed the therapeutic potential of targeting NF-κB pathway in nasopharyngeal carcinoma (NPC). However, the anticancer activity of Andro...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Tao, Hu, Min, Wu, Ting-Ting, Zhang, Cen, Chen, Zhe, Huang, Shuo, Zhou, Xu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377360/
https://www.ncbi.nlm.nih.gov/pubmed/25861643
http://dx.doi.org/10.1155/2015/735056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377360/
https://www.ncbi.nlm.nih.gov/pubmed/25861643
http://dx.doi.org/10.1155/2015/735056

Ejemplares similares